Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
LGND Stock — Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated (LGND)
Updated October 16, 2026.
LGND is a Stock. Total return is 841.6% over the past 33.9 years.
Ligand Pharmaceuticals is a biopharmaceutical company that develops and licenses drugs across multiple therapeutic areas, including infectious disease, oncology, immunology, and rare diseases. The company does not currently distribute dividends to shareholders. This security appeals to investors seeking equity exposure to the pharmaceutical sector rather than income-focused investors.
LGND dividend yield and income
Price as of 2026-10-16.
The ex-dividend date is 07/02/2010.
| Ex-date | As paid | Per current share | Change from previous payment |
|---|---|---|---|
| 2010-07-02 | $0.12183 | $0.456 | -95.1% Unclassified cash |
| 2007-04-03 | $2.5 | $9.3575 | — |
| 2007 total | — | $9.3575 | — |
| 2010 total | — | $0.456 | -95.1% |
LGND performance
Price and return data through 2026-10-16.
Total return is 841.6% over the past 33.9 years. Over the past year its total return — price change plus distributions reinvested — is 63.5%. Its deepest 1-year drawdown was 14.7%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | 7.4% | — |
| 3M | -0.3% | — |
| 6M | 32.4% | — |
| YTD | 56.3% | — |
| 1Y | 63.5% | — |
| 2Y CAGR | — | 66.10% |
| 3Y CAGR | — | 73.70% |
| 5Y CAGR | — | 29.50% |
| 10Y CAGR | — | 17.70% |
| Since inception (33.9 years) | 841.6% | 6.80% |
LGND key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 11/18/1992
- Distribution frequency
- None
- Last close
- $295.54 (as of 2026-10-16)
- Market cap
- $5,891,769,884
- Average volume
- 164500.0
- Ex-dividend date
- 07/02/2010
- Beta
- 1.008
- Payout ratio
- 0.0%
- P/E ratio
- 31.14
- Forward P/E
- 24.8139
- EPS
- $9.49
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
LGND risks and drawbacks
The deepest 1-year drawdown on record here is 14.7%.
Who may consider LGND — and who may not
It is a weaker fit for investors who need monthly cash flow (LGND does not currently distribute). This is educational context, not a recommendation to buy or sell.
More on LGND
Frequently asked questions
Does LGND pay monthly?
No. LGND does not currently distribute.
When does LGND pay a dividend?
LGND does not currently distribute. The ex-dividend date is 07/02/2010.
How has LGND performed?
Total return is 841.6% over the past 33.9 years. Over the past year its total return — price change plus distributions reinvested — is 63.5%. Its deepest 1-year drawdown was 14.7%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.